Showing results (1-10 of 331) with videos related to
Sort By:
Pageof 34
Headache|November 1, 1996
Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal painF M Cutrer, M A MoskowitzAnnual Review of Medicine|January 1, 1993
SUMATRIPTAN: a receptor-targeted treatment for migraineM A Moskowitz, F M CutrerCurrent Opinion in Neurology|June 1, 1996
Neurotransmitters and neuropeptides in headacheV Limmroth, F M Cutrer, M A MoskowitzCephalalgia : an International Journal of Headache|April 1, 1997
Possible mechanisms of valproate in migraine prophylaxisF M Cutrer, V Limmroth, M A MoskowitzBritish Journal of Pharmacology|December 1, 1995
Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicinF M Cutrer, V Limmroth, G Ayata, et al.Neuroscience|February 1, 1995
The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulationF M Cutrer, S Moussaoui, C Garret, et al.Neuropharmacology|January 1, 1997
The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura materX J Yu, F M Cutrer, M A Moskowitz, et al.British Journal of Pharmacology|March 1, 1995
Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicinF M Cutrer, D Schoenfeld, V Limmroth, et al.Neuropharmacology|July 31, 1999
Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalisF M Cutrer, X J Yu, G Ayata, et al.Pain|August 8, 1998
The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalisD D Mitsikostas, M Sanchez del Rio, C Waeber, et al.Pageof 34